The primary objective of this paper is to delineate and elucidate the contemporary
advancements, developments, and prevailing trajectories concerning intrastent restenosis …

In-stent restenosis is the limiting entity following coronary stent implantation. It is associated
with significant morbidity and cost and thus represents a major clinical and economical …

The introduction and subsequent iterations of drug-eluting stent technologies have
substantially improved the efficacy and safety of percutaneous coronary interventions …

The lumen diameter reduction after percutaneous coronary intervention (PCI) is well known
as “restenosis”. This phenomenon is due to vessel remodeling/recoil in case of no-stent …

Percutaneous transluminal coronary angioplasty has revolutionized the management of
patients with coronary artery disease. Unfortunately, the procedure's utility is limited by a …

Abstract Purpose of Review This review will focus on our approach for the treatment of
refractory in-stent restenosis. Recent Findings The discovery of bare metal stents over three …

Nowadays stent placement has replaced balloon angioplasty as the most commonly
performed percutaneous coronary interventional procedure, mainly because of its better …

Treatments of atherogenesis, one of the most common cardiovascular diseases (CVD), are
continuously being made thanks to innovation and an increasingly in-depth knowledge of …

The occurrence of in-stent restenosis (ISR) still remains a daunting challenge in the current
era, despite advancements in coronary intervention technology. The authors explore the …

Although stents mitigate the risk of restenosis, in-stent restenosis (ISR) is still an important
clinical problem. ISR usually occurs within the first 3 to 6 months after stenting, with little …